Murphy Andrew J 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/3/15 申報
- 申報編號
- 0001968202-24-000086
- 申報時間
- 2024/3/15
- 交易日
- 2024/3/13-3/14
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 16 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $553.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Murphy Andrew JCIK 0001796226 | 高階主管（EVP Research） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/3/13 | Common Stock | M行使選擇權取得 | +20,000 | $399.66 | +$7,993,200 | 68,306 | 直接 | |
| 2024/3/13 | Common Stock | F扣股繳稅處分 | −14,217 | $971.82 | −$13,816,364.94 | 54,089 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −182 | $951.92F2 | −$173,249.44 | 53,907 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −444 | $952.40F3 | −$422,865.6 | 53,463 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −576 | $953.77F4 | −$549,371.52 | 52,887 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −870 | $954.66F5 | −$830,554.2 | 52,017 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −545 | $955.54F6 | −$520,769.3 | 51,472 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −1,108 | $956.34F7 | −$1,059,624.72 | 50,364 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −730 | $957.35F8 | −$698,865.5 | 49,634 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −477 | $958.34F9 | −$457,128.18 | 49,157 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −512 | $959.36F10 | −$491,192.32 | 48,645 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −47 | $961.74 | −$45,201.78 | 48,598 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −1 | $962.87 | −$962.87 | 48,597 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −78 | $965.51F11 | −$75,309.78 | 48,519 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −17 | $966.30 | −$16,427.1 | 48,502 | 直接 | |
| 2024/3/14 | Common Stock | S賣出處分 | −196 | $968.20F12 | −$189,767.2 | 48,306 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/3/13 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 20,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 182 shares of Company stock on March 14, 2024 at prices ranging from $951.89 to $951.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 444 shares of Company stock on March 14, 2024 at prices ranging from $952.00 to $952.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 576 shares of Company stock on March 14, 2024 at prices ranging from $953.30 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 870 shares of Company stock on March 14, 2024 at prices ranging from $954.01 to $954.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 545 shares of Company stock on March 14, 2024 at prices ranging from $955.02 to $955.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 1,108 shares of Company stock on March 14, 2024 at prices ranging from $956.08 to $956.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 730 shares of Company stock on March 14, 2024 at prices ranging from $957.02 to $957.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 477 shares of Company stock on March 14, 2024 at prices ranging from $958.06 to $958.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents volume-weighted average price of sales of 512 shares of Company stock on March 14, 2024 at prices ranging from $959.13 to $959.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F11
Represents volume-weighted average price of sales of 78 shares of Company stock on March 14, 2024 at prices ranging from $965.26 to $965.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F12
Represents volume-weighted average price of sales of 196 shares of Company stock on March 14, 2024 at prices ranging from $968.15 to $968.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。